EHP, 2014, Vol 16(1), pp 717
Approved by the FDA in 2017 under the brand name Ozempic for the treatment of type 2 diabetes, and later, as Wegovy for weight management, semaglutide has shown significant benefits in clinical trials, improving glycemic control and facilitating substantial weight loss
Am J Clin Exp Immunol
Semaglutide offers a safe, effective, and well-rounded approach to weight loss, and when paired with lifestyle changes, it can help individuals achieve lasting success
As with most medications, Ozempic ( Semaglutide GLP-1 ) does come with some side effects so it will only be recommended for patients who would benefit from the medication, in this case for weight loss , and will be closely supervised throughout the process to ensure that it continues to work and be a safe fit for them